About: Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations
Creator	Donalisio, Maria Freitas, Ribas Ricardo, André
Source	Medline; PMC
abstract	Respiratory syncytial virus (RSV) infection is the leading cause of hospitalisation for respiratory diseases among children under 5 years old. The aim of this study was to analyse RSV seasonality in the five distinct regions of Brazil using time series analysis (wavelet and Fourier series) of the following indicators: monthly positivity of the immunofluorescence reaction for RSV identified by virologic surveillance system, and rate of hospitalisations per bronchiolitis and pneumonia due to RSV in children under 5 years old (codes CID-10 J12.1, J20.5, J21.0 and J21.9). A total of 12,501 samples with 11.6% positivity for RSV (95% confidence interval 11 - 12.2), varying between 7.1 and 21.4% in the five Brazilian regions, was analysed. A strong trend for annual cycles with a stable stationary pattern in the five regions was identified through wavelet analysis of the indicators. The timing of RSV activity by Fourier analysis was similar between the two indicators analysed and showed regional differences. This study reinforces the importance of adjusting the immunisation period for high risk population with the monoclonal antibody palivizumab taking into account regional differences in seasonality of RSV.
has issue date	2016-05-01(xsd:dateTime)
bibo:doi	10.1590/0074-02760150341
bibo:pmid	27120006
has license	cc-by
sha1sum (hex)	c2749a18c00e1668167a5f65d6d9ff7896f25465
schema:url	https://doi.org/10.1590/0074-02760150341
resource representing a document's title	Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations
has PubMed Central identifier	PMC4878298
has PubMed identifier	27120006
schema:publication	Mem Inst Oswaldo Cruz
resource representing a document's body	covid:c2749a18c00e1668167a5f65d6d9ff7896f25465#body_text
is schema:about of	named entity 'RSV' named entity 'immunisation' named entity 'RSV' named entity 'analysed' named entity 'SEASONALITY' named entity 'RISK POPULATIONS' named entity 'CAUSE' named entity 'J20' named entity '11.6' named entity 'PNEUMONIA' named entity 'ACTIVITY' named entity 'ADJUSTING' named entity 'FOURIER ANALYSIS' named entity 'REACTION' named entity 'TAKING' named entity 'AT-' named entity 'SIMILAR' named entity 'SEASONALITY' named entity 'HOSPITALISATION' named entity 'VIROLOGIC' named entity 'TOTAL' named entity 'AIM' named entity 'SAMPLES' named entity 'J12' named entity 'TREND' named entity 'FOURIER' named entity 'SURVEILLANCE SYSTEM' named entity 'FOLLOWING' named entity 'PERIOD' named entity 'BRONCHIOLITIS' named entity 'REGIONS' named entity 'RATE' named entity 'PATTERN' named entity 'SERIES' named entity 'STATIONARY' named entity 'RESPIRATORY DISEASES' named entity 'IDENTIFIED BY' named entity 'HIGH RISK POPULATION' named entity 'IMMUNISATION' named entity 'RESPIRATORY SYNCYTIAL VIRUS' named entity 'POLICY' named entity 'CHILDREN' named entity 'ACCOUNT' named entity 'UNDER 5 YEARS OLD' named entity 'J21' named entity 'CONFIDENCE INTERVAL' named entity 'DISTINCT' named entity 'INFECTION' named entity 'DUE TO' named entity 'TIMING' named entity 'WAVELET ANALYSIS' named entity 'USING' named entity 'STABLE' named entity 'INDICATORS' named entity 'ANNUAL' named entity 'BRAZIL' named entity 'MONTHLY' named entity 'BRAZIL' named entity 'MONOCLONAL ANTIBODY' named entity 'RSV' named entity 'STRONG' named entity 'IDENTIFIED' named entity 'RESPIRATORY SYNCYTIAL VIRUS' named entity 'VARYING' named entity 'CID' named entity 'IMMUNISATION' named entity 'LEADING' named entity 'REGIONAL DIFFERENCES' named entity 'PALIVIZUMAB' named entity 'STUDY' named entity 'IMMUNOFLUORESCENCE' named entity 'TIME SERIES ANALYSIS' named entity 'BRAZILIAN' covid:arg/c2749a18c00e1668167a5f65d6d9ff7896f25465 named entity 'aim' named entity 'samples' named entity 'analyse' named entity 'indicators' named entity 'seasonality'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software